Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells - 30/03/13
Doi : 10.1016/j.jaci.2013.01.031
Jamma Trinath, MSc a, b, Pushpa Hegde, MSc a, c, Kithiganahalli N. Balaji, PhD b, Srini V. Kaveri, DVM, PhD a, d, e, f 
, Jagadeesh Bayry, DVM, PhD a, d, e, f
, Jagadeesh Bayry, DVM, PhD a, d, e, f a Unité 872, Institut National de la Santé et de la Recherche Médicale, Paris, France
b Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India
c Université de Technologie de Compiègne, Compiègne, France
d Centre de Recherche des Cordeliers, Equipe 16- Immunopathology and therapeutic immunointervention, Université Pierre et Marie Curie – Paris 6, Paris, France
e Université Paris Descartes, Paris, France
f International Associated Laboratory IMPACT (Institut National de la Santé et de la Recherche Médicale, France - Indian council of Medical Research, India), National Institute of Immunohaematology, Mumbai, India
Le texte complet de cet article est disponible en PDF.
| This study was supported by Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, Université Paris Descartes (to S.V.K. and J.B.), Centre National de la Recherche Scientifique (to S.V.K.), European Community’s Seventh Framework Programme (FP7/2007-2013, HEALTH-2010.2.4.5-2) under grant agreement HEALTH-No.: 260338 ALLFUN (to J.B.), Indian Institute of Science, Department of Biotechnology, Department of Science and Technology, Council for Scientific and Industrial Research (to K.N.B.), Coopération INSERM-ICMR-AO 2009/2010 (to K.N.B. and J.B.), and fellowships from INSERM-ICMR, Council for Scientific and Industrial Research (to J.T.). |
|
| Disclosure of potential conflict of interest: J. Trinath has received grants from INSERM-ICMR, Council for Scientific and Industrial Research, Government of India. S. V. Kaveri has received grants from Talecris Biotherapeutics. K. Balaji has received grants from the Department of Biotechnology, Department of Science and Technology, Council for Scientific and Industrial Research, Government of India (Coopération INSERM-ICMR-AO 2009/2010). J. Bayry has received grants from the European Community’s Seventh Framework Programme (FP7/2007-2013, HEALTH-2010.2.4.5-2) under grant agreement HEALTH-No.: 260338 ALLFUN; Coopération INSERM-ICMR-AO 2009/2010; and Talecris Biotherapeutics. P. Hegde declares that she has no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 4
P. 1255 - avril 2013 Retour au numéro
Article précédent
- Reply
- Paul Michel Mertes, Pascal Demoly, Annick Alperovitch, Agnes Bazin, Jacques Bienvenu, Cyril Caldani, Bernard Lamy, Dominique Laroche, Marie Françoise Leconte des Floris, Jean-Yves Py, Christian Drouet, Monique Carlier, Andre Lienhart
- Reply
- Amir H. Massoud, Gabriel N. Kaufman, M. Walid Mourad, Ciriaco Piccirillo, Bruce D. Mazer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?